Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer - Contacts and Locations

Home

Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer

This study has been completed.

Study NCT00009971. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00009971

Locations


United States, Michigan
	Barbara Ann Karmanos Cancer Institute
	Detroit, Michigan, United States, 48201-1379
	University of Michigan Comprehensive Cancer Center
	Ann Arbor, Michigan, United States, 48109-0752

Sponsors and Collaborators

University of Michigan Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Gregory P. Kalemkerian, MD	University of Michigan Cancer Center